Novel chimeric β-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 β-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 1, 2009, Pages 69-74

  Nagano, Yukiko ^a   Nagano, Noriyuki ^a,b   Wachino, Jun Ichi ^a   Ishikawa, Keiko ^c   Arakawa, Yoshichika ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b Funabashi Municipal Medical Center   (Japan)

^c Urayasu Ichikawa City Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE; BETA LACTAMASE CTX M 14; BETA LACTAMASE CTX M 15; BETA LACTAMASE CTX M 64; CEFACLOR; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFMETAZOLE; CEFOTAXIME; CEFOTETAN; CEFOTIAM; CEFOXITIN; CEFOZOPRAN; CEFPIROME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CEPHALOSPORINASE; CHIMERIC PROTEIN; CLAVULANIC ACID; FLOMOXEF; NITROCEFIN; PIPERACILLIN; SULPERAZON; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA DETERMINATION; ENZYME ANALYSIS; ENZYME KINETICS; ENZYME STRUCTURE; GENE SEQUENCE; GENETIC RECOMBINATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; SHIGELLA SONNEI;

AMINO ACID SEQUENCE; BETA-LACTAMASES; BLOTTING, SOUTHERN; CEFTAZIDIME; CEPHALOSPORINS; KINETICS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID; SHIGELLA SONNEI;

EID: 59749087142     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00227-08     Document Type: Article

References (35)

1. Acikgoz, Z. C., Z. Gulay, M. Bicmen, S. Gocer, and S. Gamberzade. 2003. CTX-M-3 extended-spectrum β-lactamases in a Shigella sonnei clinical isolate: first report from Turkey. Scand. J. Infect. Dis. 35:503-505.
2. Bonnet, R., C. Recule, R. Baraduc, C. Chanal, D. Sirot, C. De Champs, and J. Sirot. 2003. Effect of D240G substitution in a novel ESBL CTX-M-27. J. Antimicrob. Chemother. 52:29-35.
3. Chanawong, A., F. H. M'Zali, J. Heritage, J. H. Xiong, and P. M. Hawkey. 2002. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob. Agents Chemother. 46:630-637.
4. Christensen, W. B. 1949. Hydrogen sulfide production and citrate utilization in the differentiation of enteric pathogens and coliform bacteria. Research bulletin no. 1. Weld County Health Department, Greeley, CO.
5. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A7, 7th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing. Eighteenth information supplement (M100-S18). Clinical and Laboratory Standards Institute, Wayne, PA.
7. Doi, Y., J. Wachino, M. Ishiguro, H. Kurokawa, K. Yamane, N. Shibata, K. Shibayama, K. Yokoyama, H. Kato, T. Yagi, and Y. Arakawa. 2004. Inhibitor-sensitive AmpC β-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins. Antimicrob. Agents Chemother. 48:2652-2658.
8. Dutour, C., R. Bonnet, H. Marchandin, M. Boye, C. Chanal, D. Sirot, and J. Sirot. 2002. CTX-M-1, CTX-M-3, and CTX-M-14 β-lactamases from Enterobacteriaceae isolated in France. Antimicrob. Agents Chemother. 46:534-537.
9. Dutta, S., D. Dutta, P. Dutta, S. Matsushita, S. K. Bhattacharya, and S.-I. Yoshida. 2003. Shigella dysenteriae serotype 1: Kolkata, India. Emerg. Infect. Dis. 9:1471-1474.
10. CTX-M genes. J. Antimicrob. Chemother. 57:14-23.
11. Kim, S., J. Kim, Y. Kang, Y. Park, and B. Lee. 2004. Occurrence of extended-spectrum β-lactamases in members of the genus Shigella in the Republic of Korea. J. Clin. Microbiol. 42:5264-5269.
12. Kimura, S., M. Ishiguro, Y. Ishii, J. Alba, and K. Yamaguchi. 2004. Role of a mutation at position 167 of CTX-M-19 in ceftazidime hydrolysis. Antimicrob. Agents Chemother. 48:1454-1460.
13. Kimura, S., Y. Ishii, K. Tateda, and K. Yamaguchi. 2007. Predictive analysis of ceftazidime hydrolysis in CTX-M-type β-lactamase family members with a mutational substitution at position 167. Int. J. Antimicrob. Agents 29:326-331.
14. Kotloff, K. L., J. P. Winickoff, B. Ivanoff, J. D. Clemens, D. L. Swerdlow, P. J. Sansonetti, G. K. Adak, and M. M. Levine. 1999. Global burden of Shigella infections: implications for vaccine development and implementation. Bull. W. H. O. 77:651-656.
15. Lartigue, M. F., L. Poirel, J. W. Decousser, and P. Nordmann. 2005. Multidrug-resistant Shigella sonnei and Salmonella enterica serotype Typhimurium isolates producing CTX-M β-lactamases as causes of community-acquired infection in France. Clin. Infect. Dis. 40:1069-1070.
16. Li, H., and J. B. Li. 2005. Detection of five novel CTX-M-type extended spectrum beta-lactamases with one to three CTX-M-14 point mutations in isolates from Hefei, Anhui Province, China. J. Clin. Microbiol. 43:4301-4302.
17. Livermore, D. M., R. Canton, M. Gniadkowski, P. Nordmann, G. M. Rossolini, G. Arlet, J. Ayala, T. M. Coque, I. Kern-Zdanowicz, F. Luzzaro, L. Poirel, and N. Woodford. 2007. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-174.
18. Mahoney, F. J., T. A. Farley, D. F. Burbank, N. H. Leslie, and L. M. McFarland. 1993. Evaluation of an intervention program for the control of an outbreak of shigellosis among institutionalized persons. J. Infect. Dis. 168:1177-1180.
19. Munday, C. J., J. Xiong, C. Li, D. Shen, and P. M. Hawkey. 2004. Dissemination of CTX-M type β-lactamases in Enterobacteriaceae isolates in the People's Republic of China. Int. J. Antimicrob. Agents 23:175-180.
20. Nagano, N., C. Cordevant, and Y. Nagano. 2008. Upper and lower urinary tract infection caused by Klebsiella pneumoniae serotype K2 and CTX-M-15 β-lactamase-producing serotype K1: a case report and characterization of serum killing resistance. J. Med. Microbiol. 57:121-124.
21. Nagano, N., Y. Nagano, C. Cordevant, N. Shibata, and Y. Arakawa. 2004. Nosocomial transmission of CTX-M-2 β-lactamase-producing Acinetobacter baumannii in a neurosurgery ward. J. Clin. Microbiol. 42:3978-3984.
22. Pimkin, M., and M. Edelstein. 2005. Improved PCR detection and subtyping of CTX-M-β-lactamase-encoding genes, abstr. 649. Abstr. 15th Eur. Congr. Clin. Microbiol. Infect. Dis.
23. Pitout, J. D. D., A. Hossain, and N. D. Hanson. 2004. Phenotypic and molecular detection of CTX-M-β-lactamases produced by Escherichia coli and Klebsiella spp. J. Clin. Microbiol. 42:5715-5721.
24. Poirel, L., M. Gniadkowski, and P. Nordmann. 2002. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum β-lactamase CTX-M-15 and of its structurally related β-lactamase CTX-M-3. J. Antimicrob. Chemother. 50:1031-1034.
25. Radice, M., C. González, P. Power, M. C. Vidal, and G. Gutkind. 2001. Third-generation cephalosporin resistance in Shigella sonnei, Argentina. Emerg. Infect. Dis. 7:442-443.
26. Rodríguez, M. M., P. Power, M. Radice, C. Vay, A. Famiglietti, M. Galleni, J. A. Ayala, and G. Gutkind. 2004. Chromosome-encoded CTX-M-3 from Kluyvera ascorbata: a possible origin of plasmid-borne CTX-M-1-derived cefotaximases. Antimicrob. Agents Chemother. 48:4895-4897.
27. Salam, M. A., and M. L. Bennish. 1991. Antimicrobial therapy for shigellosis. Rev. Infect. Dis. 13(Suppl. 4):S332-S341.
28. Sivapalasingam, S., J. M. Nelson, K. Joyce, M. Hoekstra, F. J. Angulo, and E. D. Mintz. 2006. High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Antimicrob. Agents Chemother. 50:49-54.
29. von Seidlein, L., D. R. Kim, M. Ali, H. Lee, X. Wang, V. D. Thiem, G. Canh do, W. Chaicumpa, M. D. Aqtini, A. Hossain, Z. A. Bhutta, C. Mason, O. Sethabutr, K. Talukder, G. B. Nair, J. L. Deen, K. Kotloff, and J. Clemens. 2006. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med. 3:e353.
30. CMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19. Antimicrob. Agents Chemother. 50:534-541.
31. Welch, T. J., W. F. Fricke, P. F. McDermott, D. G. White, M. L. Rosso, D. A. Rasko, M. K. Mammel, M. Eppinger, M. J. Rosovitz, D. Wagner, L. Rahalison, J. E. Leclerc, J. M. Hinshaw, L. E. Lindler, T. A. Cebula, E. Carniel, and J. Ravel. 2007. Multiple antimicrobial resistance in plague: an emerging public health risk. PLoS One 2:e309.
32. Wilson, G., J. M. Easow, C. Mukhopadhyay, and P. G. Shivananda. 2006. Isolation & antimicrobial susceptibility of Shigella from patients with acute gastroenteritis in western Nepal. Indian J. Med. Res. 123:145-150.
33. Woodford, N., E. J. Fagan, and M. J. Ellington. 2006. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J. Antimicrob. Chemother. 57:154-155.
34. World Health Organization. 2005. Shigellosis: disease burden, epidemiology and case management. Wkly. Epidemiol. Rec. 80:94-99.
35. Yu, W. L., P. L. Winokur, D. L. Von Stein, M. A. Pfaller, J. H. Wang, and R. N. Jones. 2002. First description of Klebsiella pneumoniae harboring CTX-M beta-lactamases (CTX-M-14 and CTX-M-3) in Taiwan. Antimicrob. Agents Chemother. 46:1098-1100.